Marijke van den Berg

2.4k citations

24 papers · 1.8k indexed · 1 hit paper · h-index 16

Hematology top 0.5%
- Hemophilia Treatment and Research 18
- Blood Coagulation and Thrombosis Mechanisms 8
- Platelet Disorders and Treatments 7
Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
Internal Medicine top 10%
Complementary and Manual Therapy top 5%
Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms 2
Molecular Biology
- Glycosylation and Glycoproteins Research 1
Surgery
- Orthopaedic implants and arthroplasty 1
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 1

Co-authors: Eveline P. Mauser‐Bunschoten I.R.O. Nováková Bert Verbruggen H. Wessels J.B.M. Boezeman G. Roosendaal Pia Petrini Floris P. J. G. Lafeber
Cited by: Hematology Genetics Internal Medicine
Journals: Haemophilia (7 papers)Blood (3 papers)Thrombosis and Haemostasis (2 papers)
Partner nations: Netherlands Sweden Germany

In The Last Decade

Marijke van den Berg

22 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Marijke van den Berg

Since Specialization

Citations

This map shows the geographic impact of Marijke van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke van den Berg more than expected).

Fields of papers citing papers by Marijke van den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke van den Berg. The network helps show where Marijke van den Berg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marijke van den Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marijke van den Berg Line = papers co-authored together Marijke van den Berg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors – lessons learned from the PedNet prospective cohort study Journal of Thrombosis and Haemostasis ·Manuel Carção,Christoph Königs,Nadine G. Andersson,S. Kim,Rino Pb,Yves Mouser,Jan Blatný,Martin Olivieri,Marijke van den Berg,Anna-Maria Wiljanen	2025	0
2	Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study Haematologica ·Christoph Male,Nadine G. Andersson,Anne Rafowicz,Ri Liesner,Karin Kurnik,Kathelijn Fischer,Helen Platokouki,Elena Santagostino,Hérvè Chambost,Beatrice Nolan,Christoph Königs,Gili Kenet,Rolf Ljung,Marijke van den Berg,Raphael Stübe	2020	77
3	The Fourth Annual Meeting of the International Network for Pediatric Hemophilia: Current Challenges and Recommendations in the Clinical Care of Children with Hemophilia Transfusion Medicine and Hemotherapy ·Rolf Ljung,Marijke van den Berg,Leonard A. Valentino,M L Manco-Johnson	2010	5
4	Risk of Inhibitor Development in Children with Haemophilia A European Oncology & Haematology ·Marijke van den Berg	2007	1
5	Hemophilia joint health score reliability study Haemophilia ·Pamela Hilliard,Sharon Funk,N. Zourikian,Dafa maulana eka Herdian Afnani,Peter Telidecki,M. McLimont,Marilyn J. Manco‐Johnson,Pia Petrini,Marijke van den Berg,Brian M. Feldman	2006	275
6	Managing the Pediatric Patient and the Adolescent/Adult Transition Seminars in Thrombosis and Hemostasis ·Leonard A. Valentino,Elena Santagostino,Victor S. Blanchette,Marijke van den Berg	2006	2
7	O-Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels. Blood ·Peter J. Lenting,Ishani Banik,Ton Lisman,Marijke van den Berg,Jeroen Eikenboom,Frank W.G. Leebeek,Jenny Goudemand,Édith Fressinaud,Philip G. de Groot,Cécile V. Denis	2006	2
8	Cost effectiveness of haemophilia treatment: a cross-national assessment Blood Coagulation & Fibrinolysis ·Barbara Lippert,Karin Berger,Erik Berntorp,Paul Giangrande,Marijke van den Berg,Wolfgang Schramm,Uwe Siebert	2005	43
9	Outcome measures in haemophilia: more than just factor levels Haemophilia ·Rhonda L. Bohn,W. Schramm,Monika Bullinger,Marijke van den Berg,Victor S. Blanchette	2004	17
10	Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions Haemophilia ·M. J. Manco‐Johnson,H. Pettersson,Pia Petrini,B Gold,Dafa maulana eka Herdian Afnani,Peter Telidecki,Andrea Doria,B. M. Feldman,Sharon Funk,Pamela Hilliard,Ray F. Kilcoyne,نبيل فولي محمد,Rachelle Nuss,Georges‐Étienne Rivard,Marja Schoenmakers,Marijke van den Berg,Jerome D. Wiedel,N. Zourikian,V. Blanchette	2004	48
11	Short-Term Exposure of Cartilage to Blood Results in Chondrocyte Apoptosis American Journal Of Pathology ·恭人間庭,G. Roosendaal,M. J. G. Wenting,Marijke van den Berg,J. W. J. Bijlsma,Floris P. J. G. Lafeber	2003	138
12	Blood-induced joint damage: longterm effects in vitro and in vivo. PubMed ·恭人間庭,G. Roosendaal,Marieke E. Vianen,Marijke van den Berg,J. W. J. Bijlsma,Floris P. J. G. Lafeber	2003	105
13	Pilot testing of the ‘Haemo‐QoL’ quality of life questionnaire for haemophiliac children in six European countries Haemophilia ·Monika Bullinger,Sylvia von Mackensen,Kathelijn Fischer,Kate Khair,Corinna Petersen,Ulrike Ravens‐Sieberer,Angiola Rocino,Pierre‐Philippe Sagnier,J Tusell,Marijke van den Berg,M Vicariot	2002	78
14	The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration Thrombosis and Haemostasis ·Laurent O. Mosnier,Ton Lisman,Marijke van den Berg,He Zuxing,Joost C.M. Meijers,Bonno N. Bouma	2001	94
15	Evaluation of the Dutch Version of the Migraine Quality of Life Instrument (Msqol) and Its Application in Headache Coping Cephalalgia ·Jan Passchier,Henrik Rotvær Bratlie,SP McKenna,Marijke van den Berg,Daniel Arriola	2001	22
16	Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency Blood ·Richard van Wijk,He Zuxing,Marijke van den Berg,Eric G. Huizinga,Fredrick Wamboldt,Rob J. Kraaijenhagen,Wouter W. van Solinge	2001	58
17	Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries Haemophilia ·Rolf Ljung,José Zamora L,Felipe Ruiz Quintero,Marijke van den Berg,Hérvè Chambost,S. Claeyssens,Chris Van Geet,Anders Glomstein,Ian Hann,F. G. H. Hill,Rainer Kobelt,W. Kreuz,Giuseppe Mancuso,W. Muntean,Pia Petrini,阿九,E. Scheibel,MA Siimes,Owen Smith,J Tusell	2000	58
18	Port‐A‐Cath usage in children with haemophilia: experience of 53 cases Acta Paediatrica ·Rolf Ljung,Marijke van den Berg,Pia Petrini,Lilian Tengborn,E. Scheibel,Riitta Kekomäki,W. Effenberger	1998	74
19	The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliabilitybreakdown → Thrombosis and Haemostasis ·Bert Verbruggen,I.R.O. Nováková,H. Wessels,J.B.M. Boezeman,Marijke van den Berg,Eveline P. Mauser‐Bunschoten	1995	500
20	Collaboration between a children's hospital and a psychiatric clinic for children in the treatment of ulcerative colitis. PubMed ·Nadir Tan,Soo-Min Shin,Koen Scholten,Suzette Glasner,Marijke van den Berg,Yu Cui	1952	0

About Marijke van den Berg

Marijke van den Berg is a scholar working on Hematology, Genetics and Speech and Hearing, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (18 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Platelet Disorders and Treatments (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Glycosylation and Glycoproteins Research (1 paper), Orthopaedic implants and arthroplasty (1 paper) and Carbohydrate Chemistry and Synthesis (1 paper). The work is most often cited by research in Hematology (1.6k citations), Genetics (473 citations) and Internal Medicine (34 citations). Marijke van den Berg has collaborated with scholars based in Netherlands, Sweden and Germany. Frequent co-authors include Eveline P. Mauser‐Bunschoten, I.R.O. Nováková, Bert Verbruggen, H. Wessels, J.B.M. Boezeman, G. Roosendaal, Pia Petrini, Floris P. J. G. Lafeber, J. W. J. Bijlsma and Kathelijn Fischer. Their work appears in journals such as Haemophilia, Blood, Thrombosis and Haemostasis, Seminars in Thrombosis and Hemostasis and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact